Characterization of methylglyoxal-modified human IgG by physicochemical methods

References

• Acharya, A. S., & Manning, J. M. (1983). Reaction of glycolaldehyde with proteins: Latent crosslinking potential of alpha-hydroxyaldehydes. Proceedings of the National Academy of Sciences, 80, 3590–3594.10.1073/pnas.80.12.3590
   PubMed Web of Science ®Google Scholar
• Ahmad, R., & Ahsan, H. (2014). Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus. Clinical and Experimental Medicine, 14, 1–11.10.1007/s10238-012-0222-5
   PubMed Web of Science ®Google Scholar
• Ahmed, M. U., Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1997). Nε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochemical Journal, 324, 565–570.10.1042/bj3240565
   PubMed Web of Science ®Google Scholar
• Ahmed, U., Thornalley, P. J., & Rabbani, N. (2014). Possible role of methylglyoxal and glyoxalase in arthritis. Biochemical Society Transactions, 42, 538–542.10.1042/BST20140024
   PubMed Web of Science ®Google Scholar
• Arfat, M. Y., Ashraf, J. M., Arif, Z., Moinuddin, & Alam, K. (2014). Fine characterization of glucosylated human IgG by biochemical and biophysical methods. International Journal of Biological Macromolecules, 69, 408–415.10.1016/j.ijbiomac.2014.05.069
   PubMed Web of Science ®Google Scholar
• Arif, B., Ashraf, J. M., Moinuddin, Ahmad, J., Arif, Z., & Alam, K. (2012). Structural and immunological characterization of Amadori-rich human serum albumin: Role in diabetes mellitus. Archives of Biochemistry and Biophysics, 522, 17–25.10.1016/j.abb.2012.04.005
   PubMed Web of Science ®Google Scholar
• Baker, J. R., Zyzak, D. V., Thorpe, S. R., & Baynes, J. W. (1994). Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds. Clinical Chemistry, 40, 1950–1955.
   PubMed Web of Science ®Google Scholar
• Baron, S. (1996). Medical microbiology (4th ed.). Galveston, TX: University of Texas, Medical Branch.
   Google Scholar
• Barth, A. (2007). Infrared spectroscopy of proteins. Biochimica et Biophysica Acta (BBA) – Bioenergetics, 1767, 1073–1101.10.1016/j.bbabio.2007.06.004
   PubMed Web of Science ®Google Scholar
• Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine, 46, 223–234.10.1146/annurev.med.46.1.223
   PubMed Web of Science ®Google Scholar
• Csizmadia, A. M., Hegyi, G., Tölgyesi, F., Györgyi, A. G. S., & Nyitray, L. (1999). Fluorescence measurements detect changes in scallop myosin regulatory domain. European Journal of Biochemistry, 261, 452–458.10.1046/j.1432-1327.1999.00290.x
   PubMedGoogle Scholar
• Davies, K. J. A., Delsignore, M. E., & Lin, S. W. (1987). Protein damage and degradation by oxygen radicals. II. Modification of amino acids, Journal of Biological Chemistry, 262, 9902–9907.
   PubMed Web of Science ®Google Scholar
• Ellman, G. L. (1959). Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82, 70–77.10.1016/0003-9861(59)90090-6
   PubMed Web of Science ®Google Scholar
• Gasymov, O. K., & Glasgow, B. J. (2007). ANS fluorescence: Potential to augment the identification of the external binding sites of proteins. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1774, 403–411.10.1016/j.bbapap.2007.01.002
   PubMed Web of Science ®Google Scholar
• Gkogkolou, P., & Böhm, M. (2012). Advanced glycation end products Dermato-Endocrinology, 4, 259–270.10.4161/derm.22028
   PubMedGoogle Scholar
• Goding, J. W. (1978). Use of staphylococcal protein A as an immunological reagent. Journal of Immunological Methods, 20, 241–253.10.1016/0022-1759(78)90259-4
   PubMed Web of Science ®Google Scholar
• Groenning, M. (2010). Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils – current status. Journal of Chemical Biology, 3, 1–18.10.1007/s12154-009-0027-5
   PubMedGoogle Scholar
• Hanssen, N. M., Engelen, L., Ferreira, I., Scheijen, J. L., Huijberts, M. S., van Greevenbroek, M. M., … Schalkwijk, C. G. (2013). Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. Journal of Clinical Endocrinology and Metabolism, 98, E1369–E1373.10.1210/jc.2013-1068
   PubMed Web of Science ®Google Scholar
• Hunt, J. V., Dean, R. T., & Wolff, S. P. (1988). Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochemical Journal, 256, 205–212.10.1042/bj2560205
   PubMed Web of Science ®Google Scholar
• Islam, S., Moinuddin, Mir, A. R., Arfat, M. Y., & Alam, K. (2017). Studies on glycoxidatively modified human IgG: Implications in immuno-pathology of type 2 diabetes mellitus. International Journal of Biological Macromolecules, 104, 19–29.10.1016/j.ijbiomac.2017.05.190
   PubMed Web of Science ®Google Scholar
• Islam, S., Moinuddin, Mir, A., Raghav, A., Habib, S., & Alam, K. (2017). Glycation, oxidation and glycoxidation of IgG: A biophysical, biochemical, immunological and hematological study. Journal of Biomolecular Structure and Dynamics, 11, 1–17. doi:10.1080/07391102.2017.1365770
   Google Scholar
• Johnson, R. N., Metcalf, P. A., & Baker, J. R. (1983). Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clinica Chimica Acta, 127, 87–95.10.1016/0009-8981(83)90078-5
   PubMed Web of Science ®Google Scholar
• Kalapos, M. (2008). The tandem of free radicals and methylglyoxal. Chemico Biological Interactions, 171, 251–271.10.1016/j.cbi.2007.11.009
   PubMed Web of Science ®Google Scholar
• Khan, F., Moinuddin, Mir, A. R., Islam, S., & Alam, K. (2016). Immunochemical studies on HNE-modified HSA: Anti-HNE-HSA antibodies as a probe for HNE damaged albumin in SLE. International Journal of Biological Macromolecules, 86, 145–154.10.1016/j.ijbiomac.2016.01.053
   PubMed Web of Science ®Google Scholar
• Khurana, R., Uversky, V. N., Nielsen, L., & Fink, A. L. (2001). Is Congo red an Amyloid-speific dye? Journal of Biological Chemistry, 276, 22715–22721.10.1074/jbc.M011499200
   PubMed Web of Science ®Google Scholar
• Kuhla, B., Lüth, H. J., Haferburg, D., Boeck, K., Arendt, T., & Münch, G. (2005). Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Annals of the New York Academy of Sciences, 1043, 211–216.10.1196/annals.1333.026
   PubMed Web of Science ®Google Scholar
• Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., … Stadtman, E. R. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464–478.10.1016/0076-6879(90)86141-H
   PubMed Web of Science ®Google Scholar
• Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015). The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clinical Science, 128, 839–861.10.1042/CS20140683
   PubMed Web of Science ®Google Scholar
• Maillard, L. C., & Gautier, M. A. (1912). The reaction of amino acids with sugars: Mechanisms of melanoid formation. Comptes rendus de l’Académie des Sciences, 154, 66–68.
   Google Scholar
• Mankarious, S., Lee, M., Fischer, S., Pyun, K. H., Ochs, H. D., Oxelius, V. A., & Wedgwood, R. J. (1988). The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. Journal of Laboratory and Clinical Medicine, 112, 634–640.
   PubMed Web of Science ®Google Scholar
• de la Maza, M. P., Garrido, F., Escalante, N., Leiva, L., Barrera, G., Schnitzler, S., … Bunout, D. (2012). Fluorescent advanced glycation end-products (ages) detected by spectro-photofluorimetry, as a screening tool to detect diabetic microvascular complications. Journal of Diabetes Mellitus, 2, 221–226.10.4236/jdm.2012.22035
   Google Scholar
• Moreau, K. L., & King, J. A. (2012). Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends in Molecular Medicine, 18, 273–282.10.1016/j.molmed.2012.03.005
   PubMed Web of Science ®Google Scholar
• Neelofar, K., & Ahmad, J. (2017). An overview of in vitro and in vivo glycation of albumin: A potential disease marker in diabetes mellitus. Glycoconjugate Journal, 34, 575–584. doi:10.1007/s10719-017-9789-0
   PubMed Web of Science ®Google Scholar
• Neelofar, K., Arif, Z., Alam, K., & Ahmad, J. (2016). Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients : A physico-chemical study. Molecular Biosystem, 12, 2481–2489.10.1039/C6MB00324A
   PubMed Web of Science ®Google Scholar
• Pelton, J. T., & McLean, L. R. (2000). Spectroscopic methods for analysis of protein secondary structure. Analytical Biochemistry, 277, 167–176.10.1006/abio.1999.4320
   PubMed Web of Science ®Google Scholar
• Peppa, M., Uribarri, J., & Vlassara, H. (2003). Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clinical Diabetes, 21, 186–187.10.2337/diaclin.21.4.186
   Google Scholar
• Rabbani, N., & Thornalley, P. J. (2014). The critical role of methylglyoxal and Glyoxalase 1 in diabetic nephropathy. Diabetes, 63, 50–52.10.2337/db13-1606
   PubMed Web of Science ®Google Scholar
• Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2006). Methylglyoxal comes of AGEs. Cell, 124, 258–260.10.1016/j.cell.2006.01.002
   PubMed Web of Science ®Google Scholar
• Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., … Amano, N. (1998). Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. American Journal of Pathology, 153, 1149–1155.10.1016/S0002-9440(10)65659-3
   PubMed Web of Science ®Google Scholar
• Shaklai, N., Garlick, R. L., & Bunn, H. F. (1984). Nonenzymatic glycosylation of human serum albumin alters its conformation and function. Journal of Biological Chemistry, 259, 3812–3817.
   PubMed Web of Science ®Google Scholar
• Silva, M. S., Gomes, R. A., Ferreira, A. E., Freire, A. P., & Cordeiro, C. (2013). The glyoxalase pathway: The first hundred years … and beyond. Biochemical Journal, 453, 1–15.10.1042/BJ20121743
   PubMed Web of Science ®Google Scholar
• Sokolove, J., Johnson, D. S., Lahey, L. J., Wagner, C. A., Cheng, D., Thiele, G. M., … Robinson, W. H. (2014). Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis and Rheumatology, 66, 813–821.10.1002/art.38307
   PubMed Web of Science ®Google Scholar
• Traverso, N., Menini, S., Cottalasso, D., Odetti, P., Marinari, U. M., & Pronzato, M. A. (1997). Mutual interaction between glycation and oxidation during non-enzymatic protein modification. Biochimica et Biophysica Acta (BBA) – General Subjects, 1336, 409–418.10.1016/S0304-4165(97)00052-4
   PubMed Web of Science ®Google Scholar
• Vivian, J. T., & Callis, P. R. (2001). Mechanisms of tryptophan fluorescence shifts in proteins. Biophysical Journal, 80, 2093–2109.10.1016/S0006-3495(01)76183-8
   PubMed Web of Science ®Google Scholar
• Yanagisawa, K., Makita, Z., Shiroshita, K., Ueda, T., Fusegawa, T., Kuwajima, S., … Koike, T. (1998). Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism, 47, 1348–1353.10.1016/S0026-0495(98)90303-1
   PubMed Web of Science ®Google Scholar